海利生物
(603718)
| 流通市值：46.73亿 | | | 总市值：47.21亿 |
| 流通股本：6.49亿 | | | 总股本：6.56亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 353,232,083.01 | 362,243,931.99 | 358,503,504.83 | 77,525,211.08 |
| 交易性金融资产 | 162,588,615.35 | 113,551,968.15 | 158,580,711.43 | 143,675,920.78 |
| 应收票据及应收账款 | 105,463,747.81 | 126,856,127.76 | 108,965,294.39 | 90,817,823.18 |
| 其中：应收票据 | 2,047,095 | 1,743,295 | 543,195 | 614,960 |
| 应收账款 | 103,416,652.81 | 125,112,832.76 | 108,422,099.39 | 90,202,863.18 |
| 预付款项 | 3,710,075.19 | 3,665,987.23 | 2,818,692.69 | 7,710,601.77 |
| 其他应收款合计 | 2,812,954.06 | 3,048,359.18 | 2,924,158.3 | 106,479,598.61 |
| 存货 | 61,751,342.84 | 57,751,030.62 | 55,008,874.54 | 84,788,878.06 |
| 其他流动资产 | 1,379,700.36 | 11,238,433.34 | 4,972,944.33 | 11,650,861.07 |
| 流动资产合计 | 690,938,518.62 | 678,355,838.27 | 691,774,180.51 | 1,169,792,575.23 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | - | - | - | 12,902,809.16 |
| 固定资产 | 39,502,967 | 29,844,251.25 | 29,045,175.02 | 147,905,610.66 |
| 在建工程 | 2,661,729.7 | 21,061,557.84 | 12,717,404.34 | 754,300.97 |
| 使用权资产 | 16,209,193.38 | 18,012,035.54 | 18,837,832.91 | 4,403,362.23 |
| 无形资产 | 54,234,958.4 | 56,227,999 | 55,581,246.07 | 28,637,406.59 |
| 商誉 | 1,019,645,700.98 | 1,019,645,700.98 | 1,005,705,419.88 | 225,330,348.7 |
| 长期待摊费用 | 16,850,876.22 | 6,901,476.52 | 5,918,029.95 | 8,099,813.55 |
| 递延所得税资产 | 732,845.71 | 734,688.06 | 736,020.86 | 21,709,942.01 |
| 其他非流动资产 | 2,539,000 | 2,539,000 | 6,523,910 | 4,179,500 |
| 非流动资产合计 | 1,152,377,271.39 | 1,154,966,709.19 | 1,135,065,039.03 | 453,923,093.87 |
| 资产总计 | 1,843,315,790.01 | 1,833,322,547.46 | 1,826,839,219.54 | 1,623,715,669.1 |
| 流动负债: | | | | |
| 短期借款 | - | - | - | 60,913,429 |
| 应付票据及应付账款 | 10,776,717.14 | 9,634,642.13 | 8,795,466.25 | 21,876,109.83 |
| 应付账款 | 10,776,717.14 | 9,634,642.13 | 8,795,466.25 | 21,876,109.83 |
| 合同负债 | 7,152,182.87 | 10,346,048.79 | 9,808,394.05 | 3,428,244.66 |
| 应付职工薪酬 | 14,083,197.7 | 12,944,408.34 | 17,897,696.21 | 3,552,913.92 |
| 应交税费 | 6,674,905.36 | 6,976,093.44 | 11,811,318.93 | 1,490,744.6 |
| 其他应付款合计 | 38,353,699.75 | 39,943,918.84 | 48,269,483.41 | 279,679,100.09 |
| 一年内到期的非流动负债 | 3,039,862.41 | 2,602,841.5 | 3,660,562.74 | - |
| 其他流动负债 | 41,492.85 | 21,663.27 | 3,537.75 | 102,847.34 |
| 流动负债合计 | 80,122,058.08 | 82,469,616.31 | 100,246,459.34 | 371,043,389.44 |
| 非流动负债: | | | | |
| 租赁负债 | 12,583,091.83 | 14,157,190.1 | 13,936,850.36 | 4,074,606.31 |
| 递延收益 | - | - | - | 20,737,485.28 |
| 递延所得税负债 | 8,893,468.12 | 9,894,225.94 | 9,462,422.08 | 2,190,089.48 |
| 非流动负债合计 | 21,476,559.95 | 24,051,416.04 | 23,399,272.44 | 27,002,181.07 |
| 负债合计 | 101,598,618.03 | 106,521,032.35 | 123,645,731.78 | 398,045,570.51 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 655,662,200 | 655,662,200 | 657,900,000 | 657,900,000 |
| 资本公积 | 276,383,135.19 | 279,135,088.74 | 281,859,046.69 | 282,310,065.09 |
| 减:库存股 | 31,750,562.25 | 31,750,562.25 | 42,383,021.39 | 66,043,070 |
| 其他综合收益 | - | - | - | -1,002,592.53 |
| 盈余公积 | 108,213,650.13 | 107,480,336.81 | 106,390,165.3 | 91,289,475.37 |
| 未分配利润 | 573,123,555.67 | 566,523,735.75 | 556,712,192.16 | 308,408,915.3 |
| 归属于母公司股东权益合计 | 1,581,631,978.74 | 1,577,050,799.05 | 1,560,478,382.76 | 1,272,862,793.23 |
| 少数股东权益 | 160,085,193.24 | 149,750,716.06 | 142,715,105 | -47,192,694.64 |
| 股东权益合计 | 1,741,717,171.98 | 1,726,801,515.11 | 1,703,193,487.76 | 1,225,670,098.59 |
| 负债和股东权益合计 | 1,843,315,790.01 | 1,833,322,547.46 | 1,826,839,219.54 | 1,623,715,669.1 |
| 公告日期 | 2025-08-28 | 2025-04-22 | 2025-04-22 | 2024-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |